"Not everyone has a lot of time in the morning
Enter Tirzepatide, a breakthrough medication initially developed for Type 2 diabetes but now showing immense promise in treating sleep apnea
Eve Slater, a cardiologist by training, who later supervised product safety for the company, and said, Eve, get to the bottom of it. Slater told me recently, We sent letters to every doctor in America and ordered rapid new tests around the world
This information, interpreted with your provider, can support a more tailored medication selection conversation rather than relying solely on population-level efficacy data
Weve received lots of questions on Mounjaro vs Ozempic, so lets get into it!